BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 330 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 1.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $748,277,000 | +1.2% | 4,949,917 | -2.4% | 0.02% | +4.2% |
| Q2 2022 | $739,053,000 | +33.8% | 5,072,075 | +8.9% | 0.02% | +60.0% |
| Q1 2022 | $552,163,000 | -13.6% | 4,656,866 | +0.5% | 0.02% | -6.2% |
| Q4 2021 | $638,787,000 | -0.2% | 4,635,280 | +0.6% | 0.02% | -11.1% |
| Q3 2021 | $639,967,000 | +40.5% | 4,607,073 | -1.8% | 0.02% | +38.5% |
| Q2 2021 | $455,460,000 | +76.1% | 4,691,578 | +24.0% | 0.01% | +62.5% |
| Q1 2021 | $258,608,000 | -14.4% | 3,783,554 | +7.3% | 0.01% | -20.0% |
| Q4 2020 | $302,125,000 | +34.8% | 3,524,951 | +2.2% | 0.01% | +25.0% |
| Q3 2020 | $224,190,000 | -13.2% | 3,448,540 | -2.3% | 0.01% | -20.0% |
| Q2 2020 | $258,176,000 | +131.9% | 3,531,326 | +8.0% | 0.01% | +100.0% |
| Q1 2020 | $111,318,000 | -29.9% | 3,271,169 | +12.1% | 0.01% | -16.7% |
| Q4 2019 | $158,873,000 | +31.2% | 2,918,341 | +0.6% | 0.01% | +20.0% |
| Q3 2019 | $121,077,000 | +11.0% | 2,902,123 | +16.5% | 0.01% | 0.0% |
| Q2 2019 | $109,059,000 | -25.9% | 2,490,520 | -12.9% | 0.01% | -28.6% |
| Q1 2019 | $147,149,000 | +66.3% | 2,858,893 | +19.5% | 0.01% | +75.0% |
| Q4 2018 | $88,499,000 | +8.7% | 2,393,148 | +10.4% | 0.00% | 0.0% |
| Q3 2018 | $81,400,000 | -1.5% | 2,167,762 | +3.7% | 0.00% | 0.0% |
| Q2 2018 | $82,613,000 | +69.8% | 2,090,388 | +10.7% | 0.00% | +100.0% |
| Q1 2018 | $48,650,000 | +56.2% | 1,888,608 | +63.6% | 0.00% | +100.0% |
| Q4 2017 | $31,139,000 | -27.0% | 1,154,207 | +1.1% | 0.00% | -50.0% |
| Q3 2017 | $42,676,000 | +67.2% | 1,141,702 | +11.8% | 0.00% | +100.0% |
| Q2 2017 | $25,523,000 | – | 1,020,932 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |